key: cord-0709110-kmd39z91 authors: Devaux, Christian A.; Rolain, Jean-Marc; Raoult, Didier title: ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome date: 2020-05-06 journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi DOI: 10.1016/j.jmii.2020.04.015 sha: edd1f6a7883f238a884d4e33eafbbefe567d2b05 doc_id: 709110 cord_uid: kmd39z91 Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged in Chinese people in December 2019 and has currently spread worldwide causing the COVID-19 pandemic with more than 150,000 deaths. In order for a SARS-CoV like virus circulating in wild life for a very long time to infect the index case-patient, a number of conditions must be met, foremost among which is the encounter with humans and the presence in homo sapiens of a cellular receptor allowing the virus to bind. Recently it was shown that the SARS-CoV-2 spike protein, binds to the human angiotensin I converting enzyme 2 (ACE2). This molecule is a peptidase expressed at the surface of lung epithelial cells and other tissues, that regulates the renin-angiotensin-aldosterone system. Humans are not equal with respect to the expression levels of the cellular ACE2. Moreover, ACE2 polymorphisms were recently described in human populations. Here we review the most recent evidence that ACE2 expression and/or polymorphism could influence both the susceptibility of people to SARS-CoV-2 infection and the outcome of the COVID-19 disease. Further exploration of the relationship between the virus, the peptidase function of ACE2 and the levels of angiotensin II in SARS-CoV-2 infected patients should help to better understand the pathophysiology of the disease and the multi-organ failures observed in severe COVID-19 cases, particularly heart failure. The human coronaviruses 77 Coronaviruses (CoV) circulate in bats and generally pass over an intermediate animal host 78 before crossing species barrier to infect humans 10 . Different species of bats in China carry 79 genetically diverse coronaviruses, some of which are direct ancestors of SARS-CoV 11-13 . 80 Indeed, the first SARS-CoV that caused a human outbreak derived from SARS-like CoV 81 circulating in Chinese horseshoe Rhinolophus bats which apparently adapted to wild 82 Himalayan palm-civet before spreading in humans 14 . The MERS-CoV originated from a 83 Pipistrellus bat CoV and was probably transmitted to humans through contact with infected 84 camels 15-17 . Soon after the first outbreak of SARS-CoV-2 in humans, it was reported that this 85 new virus was related to a bat-borne coronavirus (BatCoV RaTG13) present in the 86 Rhinolophus affinis bat species 18 . The identification of an intermediate animal hosts has been 87 the subject of intense research and it was claimed that a pangolin (Manis javanica) was the 88 intermediate host for SARS-CoV-2 19 . The SARS-CoV-2 receptor ACE2 from bat and 89 pangolin and several other species, were found to resemble that of human 20 . 90 Before 2003, although human coronavirus 229E (HCoV-229E) (Alphacoronavirus) and 91 HCoV-OC43 (Betacoronavirus lineage a) described in the 1960s were known to be agents of 92 respiratory infections, they lent little attention. In the early 2000s, two other coronaviruses 93 responsible for similar diseases were identified, the HCoV-NL63 (Alphacoronavirus) and HCoV-HKU1 (Betacoronavirus lineage a). Even if the health authorities pay little attention to 95 these viruses, sometimes they can cause deaths in people with fragile health. A study in 96 Switzerland reported that among 279 subjects who had bronchoalveolar lavage for 97 investigation of respiratory symptoms, 29 were tested positive for HCoV (detection rate: 98 10.4%) 21 . A large-scale polymerase chain reaction (PCR) screening of 11,661 nasal samples 99 from European patients with respiratory disease, found 35 HCoV-229E (0.30%), 61 HCoV-100 HKU1 (0.52%), 75 HCoV-NL63 (0.64%), and 111 HCoV-OC43 (0.85%) 22 . A similar study 101 in Africa on 5,573 nasal samples from child hospitalized for pneumonia found 114 HCoV- able to spread from person-to-person leading to a fatality rate of 9.6% in infected patients, 112 causing global concern. The Middle East Respiratory Syndrome (MERS) caused by the The MERS-CoV, SARS-CoV, SARS-CoV-2 and their cellular receptors 125 Already for SARS-CoV, it was demonstrated that this virus used the angiotensin I converting 126 enzyme 2 (ACE2) to enter human cells 29 . The novel Betacoronavirus SARS-CoV-2 127 (formerly 2019-nCoV), that cause COVID-19 disease, has 79.5% nucleotide identity with 128 SARS-CoV 1 . It is worth noting that HCoV-NL63, SARS-CoV and SARS-CoV-2 spike 129 proteins bind ACE2 30 expressed at high levels in type I and II alveolar cells in the lung, 130 whereas MERS-CoV bind the dipeptidyl peptidase 4 (DPP4)/CD26), a multifunctional serine 131 peptidase known involved in T cell activation 31 . The analysis of SARS-CoV-2 spike (S) 132 protein and ACE2 three-dimensional (3-D) structures allowed identification of regions in the 133 peptidase domain of ACE2 required for viral spike binding 3 . Three very elegant papers 134 published in the recent weeks characterized SARS-CoV-2 entry in target cells through 135 interactions with ACE2 and serine protease TMPRSS2 priming as well as the 3-D structures 136 involved in these interactions 3, 32, 33 . The human monocarboxypeptidase ACE-2 was originally cloned from human heart failure 138 and lymphoma cDNA libraries 7 . Although the ACE2 gene is usually considered silent in 139 immune cells, the expression of ACE2 mRNAs was reported in a subset of CD14+ CD16-140 human monocytes 34 . ACE2 is also expressed by enterocytes of the small intestine and 141 expected to regulate the expression of the gut antimicrobial peptides 35 . Moreover, this 142 peptidase is also present on the arterial and venous endothelial cells, and arterial smooth 143 muscle 36 . In normal human lung, the ACE2 protein is found on type I and II alveolar 144 epithelial lung cells 37 . High expression of ACE2 was also reported on the epithelial cells of sometimes observed in clinic. We therefore suggest that quantification of ACE2 and AngII be 294 added to the COVID-19 patients biological monitoring. 295 It is known that ACE2 can shift the RAAS balance by conversion of Ang II to Ang (1-7) . 296 Consequently, HT and COVID-19 recently become a question of concern for international 297 professional societies of cardiology regarding: i) the susceptibility of patients with HT to get 298 COVID-19; ii) the severity of the disease; and, iii) the use of ACE inhibitors (ACEi) and 299 AngII receptor blockers (ARBs, that targets the AT 1 R). It is known that HT inhibitors such drugs on ACE2 mRNA expression in lung epithelial cells, there is a concern that patients 303 taking those treatments can favor virus capture. In patients with HT who received long-term 304 olmesartan (ARB) treatment, urinary ACE2 levels were higher than among untreated control 305 patients 103 . In contrast to HT, in patients suffering from idiopathic pulmonary fibrosis, the 306 expression levels of ACE2 are markedly decreased 30 . ACE2 is a major actor toward 307 resolution of inflammation and fibrosis 104 . In an animal model of bleomycin-induced 308 pulmonary fibrosis, treatment with intraperitoneal injection of recombinant human ACE2 309 improved the lung function and decreased lung inflammation and fibrosis 105 . Moreover, 310 impaired phosphorylation of ACE2 Ser680 by AMP-activated protein kinase in pulmonary 311 endothelium leads to a labile ACE2 and hence pulmonary HT 106 . We must also paid attention 312 to molecules such as xanthenone (XNT) and dimiazene aceturate (DIZE, an anti-313 trypanosomal drug) described as ACE2 activators 107 . In a rat model of ischemic heart disease, The mechanism of acute myocardial injury caused by SARS-CoV-2 during severe COVD-19 353 disease might be related to the inhibition of ACE2 catalytic activity 126 . (Figure 2) . 354 Interestingly, a recent study posted as a pre-print paper 127 A Novel Coronavirus from Patients with Pneumonia in 474 Clinical features of patients infected with 2019 novel 477 coronavirus in Wuhan Structural basis for the recognition of the 480 SARS-CoV-2 by full-length human ACE2 Tissue distribution of 602 ACE2 protein, the functional receptor for SARS Coronavirus Understanding of COVID-19 based on current 605 evidence High expression of ACE2 608 receptor of 2019-nCoV on the epithelial cells of orla mucosa Single-cell RNA expression profiling 611 of ACE2, the putative receptor of Wuhan 2019-nCov Tobacco-use disparity in gene expression of ACE2, the receptor of 2019-nCov Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor 619 ACE2 in different populations Collectrin, a Collecting Duct-specific Transmembrane Glycoprotein Is a Novel Homolog of ACE2 and Is Developmentally Regulated in Embryonic Kidneys A unique signature identifies a family sequence, 627 which could have better zinc-binding activity than of zinc-dependent metallopeptidases Sturrock 631 ED. Structure of Testis ACE Glycosylation Mutants and Evidence for Conserved Domain 632 Transcription of testicular 635 angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE 636 gene ACE 639 polymorphism The angiotensin I-converting enzyme Counterregulatory actions 644 of angiotensin-(1-7) The role of ACE2 in cardiovascular 647 physiology Exploring the structure and function of zinc metallopeptidases: old enzymes 650 and new discoveries Differences in the properties and enzymatic specifities 653 of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with 654 bradykinin and other natural peptides The renin-angiotensin-aldosterone system and the kidney 657 disease Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules. Int 661 A dipeptidyl 664 peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-665 proton pump exchanger-1 axis Aspects of gene polymorphisms in cardiovascular 668 disease : the renin-angiotensin system Angiotensin-(1-7) is an endogenous ligand 671 for the G protein-coupled receptor Mas Significance of angiotensin 1-7 coupling with 674 MAS1 receptor and other GPGRs to the renin-angiotensin system: IUPHAR Review 22. Brit 675 The transcription factor 678 HNF1α induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets 679 from evolutionarily conserved promoter motifs Decreased glomerular 683 and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease Ectodomain Shedding of Angiotensin Converting Enzyme 2 in Human 688 Enzyme 2 Ectodomain Shedding from Mouse Proximal Tubular 692 Cells The E-Cadherin Cleavage Associated to Pathogenic 695 Bacteria Infections Can Favor Bacterial Invasion and Transmigration, Dysregulation of the 696 Immune Response and Cancer Induction in Humans System in Heart Failure Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging Molecular mechanisms of inhibition of vascular growth by 707 angiotensin Angiotensin-converting enzyme 2 is an 710 essential regulator of heart function ACE2 gene transfer attenuates 713 hypertension-linked pathophysiological changes in the SHR Interaction of diabetes and ACE2 in the 717 pathogenesis of cardiovascular disease in experimental diabetes Angiotensin converting enzyme 2 and diminazene: 721 role in cardiovascular and blood pressure regulation Association of ACE, ACE2 and UTS2 polymorphisms 725 with essential hypertension in Han and Dongxiang populations from North-Western China Correlation of angiotensin-converting enzyme 2 729 gene polymorphisms with stage 2 hypertension in Han Chinese Polymorphisms of angiotensin-converting enzyme 733 (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in 734 hypertensive patients Impact of ACE2 gene polymorphism on antihypertensive 737 efficacy of ACE inhibitors Association of ACE2 genetic polymorphisms with hypertension-related target organ damages 741 in south The association between the angiotensin-converting enzyme-2 gene 745 and blood pressure in a cohort study of adolescents Correlation of angiotensin-converting enzyme 2 gene 748 polymorphism with antihypertensive effects of benazepril Association of angiotensin-converting enzyme 752 and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the 753 population of Odisha The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to 757 hypertension: A genetic association study in Brazilian patients Polymorphism in the Gene for Angiotensin Converting Enzyme Is Increased in African-762 Americans With Hypertension The cytoplasmic domain of CD4 plays a critical role 765 during the early stages of HIV infection in T-cells Binding of HIV-768 1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral 769 blood mononuclear cells reveals latent infection Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced 773 by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein Role of the intracytoplasmic domains of CXCR4 in SDF-1 mediated signaling 778 HIV-1 Coreceptor Activity 781 of CCR5 and Its Inhibition by Chemokines: Independence from G Protein Signaling and 782 Importance of Coreceptor Downmodulation Homozygous defect in HIV-1 corecptor accounts for 786 resistance of some multiply-exposed individuals to HIV-1 infection Resistance to HIV-1 infection in caucasian 789 individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Dipeptidyl peptidase 4 is a functional receptor for the 793 emerging human coronavirus-EMC Structure of MERS-CoV spike receptor-binding domain 796 complexed with human receptor DPP4 Middle East respiratory syndrome coronavirus 799 infection mediated by the transmembrane serine protease TMPRSS2 KLK5 induces shedding of DPP4 from circulatory 803 Th17 cells in type 2 diabetes Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of 807 Middle East respiratory syndrome coronavirus Amino acids 270 to 810 510 of the severe acute respiratory syndrome coronavirus spike protein are required for 811 interaction with receptor Receptor and viral determinants of SARS-coronavirus 814 adaptation to human ACE2 Tumor Necrosis Factor-Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-818 SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2) A crucial role of angiotensin converting enzyme 2 (ACE2) 822 in SARS coronavirus-induced lung injury Differential Downregulation of ACE2 by the Spike 826 Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63 Chloroquine is a potent inhibitor of SARS 830 coronavirus infection and spread New insights on the antiviral effects of 833 chloroquine against coronavirus: what to expect for COVID-19? The ACE2 Gene: Its Potential as a 837 Functional Candidate for Cardiovascular Disease Gender differences in urinary ACE and ACE2 activities in adolescents Sex differences in the metabolic effects of the renin-844 angiotensin system Human intestine luminal ACE2 847 and amino acid transporter expression increased by ACE-inhibitors Urinary angiotensinconverting enzyme 2 in 851 hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker. Am 852 Angiotensin II and the fibroproliferative response to acute lung injury Bleomycin-Induced Lung Injury AMP-activated Protein Kinase Phosphorylation of 863 Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension Angiotensin converting enzyme 2 and diminazene: 867 role in cardiovascular and blood pressure regulation. Curr Opinion Diminazene aceturate enhances angiotensin-870 converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology Exenatide induces an increase in 874 vasodilatory and a decrease in vasoconstrictive mediators Anticoagulant treatment is associated with decreased 878 mortality in severe coronavirus disease 2019 patients with coagulopathy Clinical Characteristics of Coronavirus Disease Clinical course and risk factors for mortality of adult in 886 patients with COVID-19 in Wuhan, China: a retrospective cohort study The Coronavirus Conundrum: ACE2 and Up-date march 17 Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and 894 Are patients with hypertension and diabetes mellitus at 897 increased risk for COVID-19 infection? Vascular inflammation and the renin-901 angiotensin system Allergic lung inflammation aggravates angiotensin II-903 induced abdominal aortic aneurysms in mice ACE and ACE2 activity in diabetic mice Deletion of angiotensin-converting enzyme 2 accelerates pressure 911 overload-induced cardiac dysfunction by increasing local angiotensin II Genetic deletion of ACE2 induces vascular dysfunction 916 in C57BL/6 mice: role of nitric oxide imbalance and oxidative stress An emergent clade 923 of SARS-CoV-2 linked to returned travellers from Iran Oral Angiotensin-(1-7) prevented 928 obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-929 fat diet High variability of TLR4 gene in 933 different ethnic groups in Iran Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to 937 severe acute respiratory syndrome coronavirus infection COVID-19 and the cardiovascular system Focusing the unfolded protein 944 response and autophagy related pathways to reposition common approved drugs against 945 A SARS-CoV-2-human protein-protein 948 interaction map reveals drug targets and potential drug repurposing Cardiology societies recommend patients taking ACE 952 inhibitors, ARBs who contract COVID-19 should continue treatment Antihypertensive drugs and risk of COVID-19 ? 958 COVID-19 and angiotensin-converting enzyme inhibitors and 962 angiotensin receptor blockers: What is the evidence? Renin-Angiotensin-Aldosterone System 966 inhibitors in patients with Covid-19 Controversies of 969 renin-angiotensin system inhibition during the COVID-19 pandemic